The Hormonal Receptor Status in Breast Cancer can be Altered by Neoadjuvant Chemotherapy: A Meta-Analysis
Authors:
- 19 September 2011
- journal article
- research article
- Published by Taylor & Francis in Cancer Investigation
- Vol. 29 (9) , 594-598
Abstract
Recently, several studies have published conflicting results on the alteration of biomarkers after neoadjuvant chemotherapy for breast cancer. This meta-analysis aims to evaluate the effects of neoadjuvant chemotherapy on biomarker status in breast cancer utilizing eligible studies identified through MEDLINE. This pooled analysis has demonstrated a significant change in estrogen receptor (p = .016) and progesterone receptor (p < .001) status before and after chemotherapy. Our findings suggest that in patients receiving neoadjuvant chemotherapy, hormonal receptor status is altered by the chemotherapy, and thus, consideration should be given to reevaluation of the HR status after administration of neoadjuvant chemotherapy.Keywords
This publication has 19 references indexed in Scilit:
- Predictors of Tumor Progression During Neoadjuvant Chemotherapy in Breast CancerJournal of Clinical Oncology, 2010
- Predictors of complete pathological response after neoadjuvant systemic therapy for breast cancerThe American Journal of Surgery, 2009
- Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancerAnnals of Oncology, 2009
- Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?Annals of Oncology, 2009
- Evaluation of ER and Ki-67 proliferation index as prognostic factors for survival following neoadjuvant chemotherapy with doxorubicin/docetaxel for locally advanced breast cancerCancer Chemotherapy and Pharmacology, 2007
- HER2/neu, p53, Ki67, and hormone receptors do not change during neoadjuvant chemotherapy in breast cancerVirchows Archiv, 2005
- Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancerBritish Journal of Cancer, 2004
- The effect of neoadjuvant chemotherapy on estrogen and progesterone receptor expression and hormone receptor status in breast cancerThe American Journal of Surgery, 2003
- Quantitative changes in cytological molecular markers during primary medical treatment of breast cancer: A pilot studyBreast Cancer Research and Treatment, 1999
- Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancerCancer Chemotherapy and Pharmacology, 1978